Solventum Corp. (SOLV)
91.83
+0.88
(+0.97%)
USD |
NYSE |
Sep 02, 16:00
91.10
-0.73
(-0.79%)
After-Hours: 20:00
Solventum Research and Development Expense (TTM) : 715.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 715.00M |
| March 31, 2026 | 721.00M |
| December 31, 2025 | 725.00M |
| September 30, 2025 | 756.00M |
| June 30, 2025 | 762.00M |
| March 31, 2025 | 770.00M |
| Date | Value |
|---|---|
| December 31, 2024 | 775.00M |
| September 30, 2024 | 766.00M |
| June 30, 2024 | 757.00M |
| March 31, 2024 | 758.00M |
| December 31, 2023 | 758.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp. | 1.606B |
| Zimmer Biomet Holdings, Inc. | 442.90M |
| Edwards Lifesciences Corp. | 1.091B |
| Intuitive Surgical, Inc. | 1.414B |
| Inspire Medical Systems, Inc. | 99.68M |